phosphotyrosine has been researched along with jtt 501 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, T; Haneda, M; Hidaka, H; Kashiwagi, A; Kikkawa, R; Kojima, H; Maegawa, H; Morino, K; Nishio, Y; Obata, T; Shibata, T; Ugi, S; Yasuda, H | 1 |
1 other study(ies) available for phosphotyrosine and jtt 501
Article | Year |
---|---|
A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle.
Topics: Animals; Blood Glucose; Drug Synergism; Glucose; Glucose Clamp Technique; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Immunosorbent Techniques; Insulin; Isoxazoles; Male; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Phosphotyrosine; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Insulin; Signal Transduction | 1999 |